Results

1–10 of 16 results for triamcinolone

Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Danny A. Mammo, MD
Annual Meeting Talks
2024
A Randomized Trial Comparing Suprachoroidal Injection of Triamcinolone and Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema
Murat Oncel, MD, FASRS
Annual Meeting Talks
2024
Efficacy of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in the Treatment of Macular Edema in Patients With Chronic Uveitis
Christopher R Henry, MD
Annual Meeting Talks
2022
Retinal Detachment Repair After Inadvertent Subretinal Injection of Triamcinolone Following an Attempted Sub-Tenon Injection
On Demand Cases, Courses, and Papers
2022
Suprachoroidal Use of Triamcinolone Acetonide: Post Hoc Analysis of PEACHTREE to Evaluate Elevations in Intraocular Pressure
On Demand Cases, Courses, and Papers
2022
Suprachoroidal Triamcinolone Acetonide Injectable Suspension for Uveitic Macular Edema: Outcomes in PEACHTREE by Baseline Disease Characteristics
On Demand Cases, Courses, and Papers
2022
Office Based Flicker ERG for Monitoring the Course of CRVO and HRVO Treated With Intravitreal Anti-VEGF and Suprachoroidal Triamcinolone Therapy
John J. Wroblewski, MD
Annual Meeting Talks
2021
Complications of Compounded Moxifloxacin-Triamcinolone
Ashkan M. Abbey, MD, FASRS, FAAO
Updates from the Field
2022
Intraocular Pressure Following Administration of Suprachoroidal Triamcinolone Acetonide Suspension: Results From the Phase 3 PEACHTREE Clinical Trial
Quan Dong Nguyen, MD, MSc, FARVO, FASRS
Annual Meeting Talks
2020
Outcomes of Sub-silicone Oil Triamcinolone Acetonide Application After 3600 Relaxing Retinectomy for Complex Retinal Detachments – A Comparative Study
Subhendu Kumar Boral, MBBS, MD(AIIMS), DNB
Annual Meeting Talks
2020